What is Pruritus Drugs Market Scope?
Pruritus is a disease occurring in an itch and a need to scratch, potential causes involve medications or pregnancy. The most common cause of pruritus is Skin disease, pregnancy, dry skin, medications can also cause pruritus. Furthermore, on very rare occasions, pruritus can be due to cancer. Pruritus is considered chronic, if itching lasts six or more weeks. The pruritus drugs are prepared in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful and provides faster. This sign can occur in isolation or can be the result of another condition. The world health organization predicts that almost 900 million people in the world at any time suffer from skin diseases, and they are amongst the most common of all human health afflictions. The skin disorder is a powerful and cardinal symptom of atopic dermatitis or atopic eczema, whose prevalence in the Western countries is estimated around 23-44 million people in America are likely to suffer from chronic pruritus.
The Pruritus Drugs market study is being classified by Type (Antimicrobial, Cardiovascular, and psychiatric/neurologic), by Application (Cholestatic pruritus, Renal pruritus, Hematologic pruritus, Idiopathic generalized pruritus, Endocrine pruritus and Pruritus related to malignancy) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Pruritus Drugs market throughout the predicted period.
Allergan Plc (Ireland), Astellas Pharma Inc.( Japan), GlaxoSmithKline Plc (United Kingdom), Pfizer Inc. (United States), Intas Pharmaceuticals Ltd(India), Johnson & Johnson(United States), Sanofi (France), Eli Lilly and Company (United States) and Merck (United States) are some of the key players profiled in the study.
Analyst at AMA have segmented the market study of Global Pruritus Drugs market by Type, Application and Region.
On the basis of geography, the market of Pruritus Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Market Trend
- High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario,
- Drug development pressure on pharmaceuticals due to future patent expiries is one of the major driving factors of the growth
- Prevalence of chronic pruritus in individuals across the globe
- Growing prevalence of target diseases, unmet needs of pruritus patients pushing the drug development and creating growth opportunities for the market
- Non-medical therapies are suggested, Acupuncture, Light therapy
- The adverse effect of the drug used to treat the pruritus
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Pruritus Drugs Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.